Clinical trials in Caceres – page 6

150 clinical trials in Caceres, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SpainEnsayosClinicos.es

Caceres at a glance

150

clinical trials

Paediatric trials0
Research sites1

Quick filters

150 trials in Caceres

Open in trial search

Seasonal allergy

Not yet recruiting

Registered drug

Study to Find the Best Dose of Beltavac with Grass Pollen Extract for Patients with Allergic Rhinoconjunctivitis, with or without Asthma

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Placebo
Sponsor:Probelte Pharma S.L.

Contact Research Centre

Acute leukaemia+2

Not yet recruiting

Registered drugNo placebo

Study Comparing Fosfomycin and Ciprofloxacin for Preventing Fever in Patients with Acute Leukemia After Chemotherapy or Stem Cell Transplant

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Ciprofloxacin
Sponsor:Fundacion Para La Investigacion Y La Innovacion Biosanitaria Del Principado De Asturias

Contact Research Centre

Acute myeloid leukaemia

Not yet recruiting

Registered drugNo placebo

Study on the Safety and Effects of AB8939 and Azacitidine for Patients with Relapsed or Refractory Acute Myeloid Leukemia

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Azacitidine
Sponsor:Ab Science

Contact Research Centre

Breast cancer female

Not yet recruiting

Registered drugNo placebo

Study of Atezolizumab, Pertuzumab, and Trastuzumab for Patients with HER2 Positive Early High-Risk and Locally Advanced Breast Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Atezolizumab
Sponsor:Fondazione Michelangelo

Contact Research Centre

Breast cancer

Not yet recruiting

Registered drugNo placebo

Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Anastrozole
Sponsor:Eli Lilly & Co.

Contact Research Centre

Acute myeloid leukaemia

Not yet recruiting

Registered drugNo placebo

Study on the Safety of Ivosidenib and Azacitidine for Adults with Newly Diagnosed IDH1m Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Azacitidine
Sponsor:Servier Affaires Medicales

Contact Research Centre

Chronic obstructive pulmonary disease

Not recruiting

Investigational

Study of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Human Igg1 Kappa Monoclonal Antibody Against Crlf2
Sponsor:Upstream Bio Inc.

Contact Research Centre

Arteriosclerosis

Not recruiting

Investigational

Study on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Pelacarsen
Sponsor:Novartis Pharma AG

Contact Research Centre

Diffuse large B-cell lymphoma

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Polatuzumab Vedotin, Rituximab, and CHP in Patients with Untreated Diffuse Large B-Cell Lymphoma

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Polatuzumab Vedotin
Sponsor:F. Hoffmann-La Roche AG

Contact Research Centre

Chronic obstructive pulmonary disease

Not recruiting

Registered drug

Study on the Effects of Astegolimab and Drug Combination for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Registered drug

Spain

Participants:18–64 years · 65+ years
Sponsor:Genentech Inc.

Contact Research Centre

Bladder cancer

Not recruiting

InvestigationalNo placebo

Study of Sasanlimab with BCG or Alone for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Not Responding to BCG

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Sasanlimab
Sponsor:Pfizer Inc.

Contact Research Centre

Acute myeloid leukaemia+1

Not recruiting

InvestigationalNo placebo

Study of RVU120 for Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride
Sponsor:Ryvu Therapeutics S.A.

Contact Research Centre

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Caceres

What the registry says about research in the country

01 Hematologic Malignancies

Clinical trials focusing on acute myeloid leukemia and related blood disorders, evaluating novel therapeutic combinations and treatment approaches.

Leukemia treatments
Drug combinations
Therapy resistance

Studies include investigations of eganelisib, RVU120, and other promising compounds for refractory conditions.

02 Cardiovascular Research

Innovative trials examining treatments for coronary artery disease and related cardiovascular conditions, including specialized therapies for arterial dissection.

Antiplatelet therapy
Stent technologies
Cardiovascular prevention

Research includes evaluation of novel medications and therapeutic approaches for various cardiac conditions.

03 Oncology Studies

Comprehensive research in breast cancer and melanoma, investigating targeted therapies and combination treatments for various cancer types.

Targeted therapies
Immunotherapy
Treatment resistance

Multiple trials exploring innovative treatment approaches for both early-stage and advanced cancers.

Back to Spain All countries